USE OF DHA, EPA OR DHA-DERIVED EPA FOR TREATING PATHOLOGY ASSOCIATED WITH CELLULAR OXIDATIVE DAMAGE

摘要

PROBLEM TO BE SOLVED: To provide manufacture of a drug for treatment of processes associated with oxidative damage, and more specifically, for treatment of processes associated with neurodegenerative, ocular, ischemic and inflammatory pathology, atherosclerosis, oxidative damage to DNA, and physical exercise.SOLUTION: The present invention provides a cellular antioxidant comprising a glyceride enriched with docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) or DHA-derived EPA.